TGFβ1-IN-1
TGFβ1-IN-1 (compound 42) is a potent, orally active TGF-β1 inhibitor. TGFβ1-IN-1 inhibits the upregulation of TGF-β1-induced fibrosis markers (α-SMA and fibronectin) and can be used in liver fibrosis disease studies[1].
Product Specifications
CAS Number
[2348795-14-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
TGF-β Receptor
Type
Reference compound
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tgfβ1-in-1.html
Purity
99.47
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1CCCC1)C2=CC=CC(NC(/C=C/C3=CC=C(OC)C=C3)=O)=C2
Molecular Formula
C22H24N2O3
Molecular Weight
364.44
Precautions
H302, H315, H319
References & Citations
[1]Lin Yue, et al. Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents. Eur J Med Chem. 2022 Nov 15;242:114685.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
226999-ML405 100 µL
HRP2 (HRPII, Histidine-rich protein 2, Malaria Histidine-rich protein 2, Malaria HRP2) (MaxLight 405) discontinued
Sign In for Pricing
View Details GTR15114673 1 Vial
Lentiviral mouse Eid3 shRNA (UAS) - Lentiviral mouse Eid3 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details